A pioneering generation: people with complex congenital heart disease living longer
People born with half a heart or single-ventricle congenital heart disease (Fontan-CHD) are now living longer than ever before, thanks to advances in medicine and technology.
It’s a hat-trick: three significant HRI NZ grants awarded
HRI is delighted to announce the award of three grants funded by HRI donors to support research into cardiovascular disease – the world’s biggest killer.
Arterial Inflammation and Redox Biology Group publishes in Nature Communications
The Arterial Inflammation and Redox Biology Group, led by Professor Roland Stocker, has published a paper in the prestigious Nature Communications journal.
HRI wins Silver in PRIA Golden Target Awards
A fundraising appeal by the Heart Research Institute (HRI) has won silver in the Golden Target Awards, run by the Public Relations Institute of Australia (PRIA).
HRI hosts two days of premier cardiovascular research
The Heart Research Institute (HRI) and Victor Chang Cardiac Research Institute (VCCRI) jointly hosted the 2021 Sydney Cardiovascular Symposium, attracting the world’s leaders at the forefront of cardiovascular research.
Dr Xuyu Liu awarded cardiovascular drug discovery grant
Congratulations to Dr Xuyu Liu on being awarded a Drug Discovery Initiative and Cardiovascular Initiative Partnership Grant for his research “A PROTAC-based bioengineering platform for more efficacious antiplatelet drug discovery”.
Quadruple success for HRI
HRI researchers have been awarded an outstanding four grants under the NSW Cardiovascular Research Capacity Program.
Silent sleep danger for smokers uncovered in world-first study
HRI scientists have discovered people who smoke and also have sleep apnoea - known as the silent killer - are putting themselves in even greater danger of future health complications.
Dr John O’Sullivan awarded 2021 Vanguard Grant
Congratulations to Dr John O’Sullivan on being awarded a Vanguard Grant for his research into “stiff” heart failure.